[Use of cardiac glycosides in chronic circulatory insufficiency].
Features specific for the action produced by the most widely employed cardiac glycosides (strophanthin, corglycon, proscillardin A, methyl- and acetyldigoxine, isolanide, digoxine and digitoxin) on the hemodynamics, peripheral resistance, electrolyte composition, acid-base equilibrium, the blood adenyl system, etc were studied in 375 patients with different stages of chronic circulatory insufficiency. The data thus made available allowed some suggestions to be made as to the choice of cardiac glycosides, the duration of their application, possible combinations thereof, and also to propose a number of measures aimed at preventing the development of poisoning with cardiac glycosides.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002301:Cardiac Glycosides / Q000506:poisoning / Q000627:therapeutic use*; D009202:Cardiomyopathies / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002319:Cardiovascular System / Q000187:drug effects; D002908:Chronic Disease; D003327:Coronary Disease / Q000188:drug therapy; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012214:Rheumatic Heart Disease / Q000188:drug therapy
D002301:Cardiac Glycosides
Primenenie serdechnykh glikozidov pri khronicheskoĭ nedostatochnosti krovoobrashcheniia